Farmak intends exports to Malaysian market by late 2018
Ukrainian pharmaceutical company Farmak plans to register its products in Malaysia by late 2018, Farmak Business Development Director Oleh Siarkevych has told Interfax-Ukraine.
He said that first the company intends to bring its strategic products to new markets, in particular, insulin and Amizonum created by the company.
In addition, the company plans to offer its ophthalmological portfolio to the Malaysian market, as well as contrast medium.
As reported, as part of the official visit of Poroshenko to Malaysia the Ukrainian-Malaysian Busines Forum was held early August. Ukrainian pharmaceutical manufacturers took part.
Advertising
Advertising
MORE ABOUT
Rada adopts at first reading deregulation of used car market
20:27, 23.04.2024
Updated memo on EFF with IMF contains 13 steps to deepen infrastructure of financial markets and supervision
20:17, 26.03.2024
Interpipe masters over 210 new types of pipe products for EU market
19:43, 26.03.2024
Govt will adopt roadmap for liberalization of gas and electricity markets – IMF memo
20:30, 25.03.2024
Ukraine to present plan to increase transparency of real estate market in March – IMF memo
19:53, 25.03.2024
LATEST
After opening of sea exports, Metinvest increases workload of factories, directs efforts to retain teams – HR Director
20:17, 06.05.2024
Kamet Steel plant carrying out major overhaul of cable rack at coke chemical division for uninterrupted power supply
19:52, 06.05.2024
Business expectations in Ukrainian construction market in Q2 decrease by 1.1 pp – statistics
19:16, 06.05.2024
Four MPC members expect reduction of key policy rate to 11.5-12% by late 2024, remaining 7 expect fall to 13% – NBU
13:58, 06.05.2024
NBU develops alternative scenario in case of higher security risks with GDP growth in 2025 by 3.3%